Merck & Co., Inc.MRK

時価総額
$2518.6億
PER
研究開発型バイオ医薬品・ワクチン・動物用製品の世界最大手。がん免疫療法やワクチン、デジタル獣医保健ソリューションを展開。2024年7月に眼科バイオ企業を約12億ドルで買収。米国・欧州・中国や新興市場を中心に展開。
2010/122011/122012/122013/122014/122015/122016/122017/122018/122019/122020/122021/122022/122023/122024/12
現金同等物10,90013,53113,45115,6217,4418,5246,5156,0927,9679,9348,1658,16712,7736,90913,318
有価証券1,3011,4412,6901,8658,2784,9037,8262,406899774--996252447
現金 + 有価証券12,20114,97216,14117,48615,71913,42714,3418,4988,86610,7088,1658,16713,7697,16113,765
売掛金-8,2617,6727,1846,6266,4847,0186,8737,0716,7787,8519,2309,45010,34910,278
商品及び製品5,8686,2546,5356,2265,5714,7004,8665,0965,4405,9786,3105,9535,9116,3586,109
流動資産合計29,06433,18134,85735,68533,17329,76430,61424,76625,87527,48327,76430,26635,72232,16838,782
有形固定資産17,08216,29716,03014,97313,13612,50712,02612,43913,29115,05317,98619,27921,42223,05123,779
投資有価証券2,1753,4587,3059,77013,51513,03911,41612,1256,2331,4697853701,015252463
固定資産合計76,71771,94771,27569,96065,16272,01564,76363,10656,76256,91463,82475,42873,43874,50778,324
総資産105,781105,128106,132105,64598,335101,77995,37787,87282,63784,39791,588105,694109,160106,675117,106
買掛金2,3082,4621,7532,2742,6252,5332,8073,1023,3183,7384,5944,6094,2643,9224,079
一年内返済予定の長期借入金---------1,9002,3002,3001,7001,3002,500
流動負債合計15,64116,24518,34817,86818,76619,20317,20418,61422,20622,22027,32723,87224,23925,69428,420
長期借入金15,48215,52516,25420,53918,69923,92924,27421,35319,80622,73625,36030,69028,74533,68334,462
資本金及び資本剰余金1,7881,7881,7881,7881,7881,7881,7881,7881,7881,7881,7881,7881,7881,7881,788
利益剰余金37,53638,99039,98539,25746,02145,34844,13341,35042,57946,60247,36253,69661,08153,89563,069
株主資本56,80556,94355,46352,32648,79144,76740,30834,56926,88226,00125,40438,25746,05837,63546,372
有利子負債合計15,48215,52516,25420,53918,69923,82924,27421,35319,80624,63627,66032,99030,44534,98336,962
純有利子負債3,2815531133,0532,98010,4029,93312,85510,94013,92819,49524,82316,67627,82223,197
DEレシオ(%)27.327.329.339.338.353.260.261.873.794.8108.986.266.19379.7
運転資本-